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Abstract
Purpose
Alpha-enolase (ENO1), a major glycolytic enzyme, is reported to be over-expressed in vari-
ous cancer tissues. It has been demonstrated to be regulated by the Hypoxia-inducible fac-
tor 1-α (HIF-1α), a crucial transcriptional factor implicated in tumor progression and cancer
angiogenesis. Choroidal neovascularization (CNV), which is a leading cause of severe
vision loss caused by newly formed blood vessels in the choroid, is also engendered by
hypoxic stress. In this report, we investigated the expression of ENO1 and the effects of its
down-regulation upon cobalt (II) chloride-induced hypoxia in retinal pigment epithelial cells,
identified as the primary source of ocular angiogenic factors.
Methods
HIF-1α-diminished retinal pigment epithelial cells were generated by small interfering RNA
(siRNA) technology in ARPE-19 cells, a human retinal pigment epithelial cell line. Both nor-
mal and HIF-1α-diminished ARPE-19 cells were then subjected to hypoxic challenge using
cobalt (II) chloride (CoCl2) or anaerobic chamber. The relation between ENO1 expression
and vascular endothelial growth factor (VEGF) secretion by retinal pigment epithelial cells
were examined. Protein levels of HIF-1α and ENO1 were analyzed using Western Blot,
while VEGF secretion was essayed by enzyme-linked immunosorbent assay (ELISA).
Cytotoxicity after hypoxia was detected by Lactate Dehydrogenase (LDH) Assay.
Results
Upon 24 hr of CoCl2-induced hypoxia, the expression levels of ENO1 and VEGF were
increased along with HIF-1α in ARPE-19 cells, both of which can in turn be down-regulated
by HIF-1α siRNA application. However, knockdown of ENO1 alone or together with HIF-1α
did not help suppress VEGF secretion in hypoxic ARPE-19 cells.
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Conclusion
ENO1 was demonstrated to be up-regulated by HIF-1α in retinal pigment epithelial cells in
response to hypoxia, without influencing VEGF secretion.
Introduction
Alpha-enolase (ENO1) belongs to the enolase family that contains three distinct isoforms,
alpha- or non-neuronal enolase, beta- or muscle-specific enolase and gamma- or neuron-spe-
cific enolase. ENO1 exists in most eukaryotic organisms and is widely distributed among differ-
ent human tissues. It functions mainly in the cytoplasm as a key glycolytic enzyme that
catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate in the glycolytic meta-
bolic pathway [1]. Glycolysis is a compensatory process of energy metabolism during hypoxia,
which is a common pathological condition contributing to diverse diseases like cancer and neo-
vascularization. In several human cancers such as breast cancer, lung adenocarcinoma, glioma,
and hepatoma, ENO1 is known to be over-expressed and its expression correlates positively
with tumor progression, angiogenesis and venous invasion. This has been validated by not only
experimental research but also clinical and pathological characteristics. Hence, ENO1 has been
considered as a potential candidate for targeted therapeutic intervention of cancer [2–7].
ENO1 is demonstrated to be up-regulated in the hypoxic cancer and brain cells under the
control of the Hypoxia-inducible factor 1-α (HIF-1α) [2, 4–8]. HIF-1α is a master regulator of
mammalian oxygen homeostasis. When cells are subjected to hypoxia, HIF-1α serves as a main
transcriptional factor activating transcription of genes encoding glycolytic enzymes, vascular
endothelial growth factor (VEGF) and other proteins that are important for maintaining oxy-
gen homeostasis via binding to the hypoxia response elements (HRE) in the promoter region
of these genes [9, 10]. However, the molecular mechanisms of ENO1 favoring cancer angiogen-
esis have not yet been clear.
ENO1 is also abundantly expressed in the eye, especially in the ocular epithelial cells where
its concentration exceeds any likely requirements for a purely glycolytic role [11]. It is initially
identified as τ crystallin expressed in the lens epithelial cells where it fulfills a structural role
important for transparency [12, 13]. In the cornea, ENO1 is found at high concentrations in
the corneal epithelial cells, making it a known marker for epithelial cell differentiation [14, 15].
Expression of ENO1 is augmented in the limbus and the cornea during epithelial regeneration
[16]. On the other hand, decreased levels of ENO1 are demonstrated in keratoconus, a non-
inflammatory disorder leading to stromal thinning and epithelial degeneration in the cornea
[17, 18]. These studies indicate that ENO1 is important for the function of the eye.
Choroidal neovascularization (CNV) is a leading cause of severe vision loss especially in
patients with age-related macular degeneration (AMD). Oxidative injury, resulting from local
hypoxia and ischemia in the choroid and the retinal pigment epithelium, has been hypothe-
sized as the key event in the initiation of CNV [19–23]CNV shares the same key contributing
factor, hypoxia, with cancer angiogenesis. ENO1, as described before, is an important player
versus hypoxic stress. However, compared with cancer angiogenesis, there is very limited
understanding of glycolytic enzymes such as ENO1 in CNV. Recent publications identifying
anti-α-enolase antibodies in the retina and sera of patients with cancer-associated retinopathy,
autoimmune retinopathy and AMD have drawn our attention into the role of ENO1 in CNV
[24–26]. In the present study, we investigated the level and regulation of ENO1 in retinal
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pigment epithelial cells upon hypoxia and its possible contribution to CNV by regulating
VEGF secretion.
Materials and Methods
Cell culture and anoxia or hypoxia treatment
ARPE-19 is a spontaneously arising human retinal pigment epithelia (RPE) cell line purchased
commercially from American Type Culture Collection (Manassas, USA). It has been widely
used for in vitro studies on the mechanisms of ocular diseases. Cells were cultured at 37°C, 21%
O2, 5%CO2, with complete Dulbecco’s modified Eagle’s medium/F12 (DMEM/F12, Invitrogen,
New York, USA) containing 10% fetal bovine serum (FBS, Hyclone, Logan, USA), 100 units/
ml penicillin (Invitrogen) and 100 μg/ ml streptomycin (Invitrogen). Cells between passages 9
to 15 were used for the experiments. 1.5×105 RPE cells/well were seeded in 6-well plates and
incubated for 48 hr. Upon reaching about 80–90% confluence, cells were rinsed with and
changed to 1ml serum-free Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen,) just
before treatment. For anoxic treatment, cells were placed in a sealed anaerobic chamber
(Thermo Fisher Scientific, New York, USA) brimmed with 95% N2 and 5% CO2. For hypoxic
treatment, the culture medium was supplemented with 300μM cobalt (II) chloride CoCl2
(Sigma, St. Louis, USA), a commonly used hypoxia-mimetic chemical. Twenty-four hr after
treatment, the culture medium was collected for Lactate Dehydrogenase assay and Enzyme-
linked immunosorbent assay (ELISA). Meanwhile, cell lysates were harvested for Western
Blotting.
Small interfering RNA (siRNA) transfection
ARPE-19 cells were transfected with ON-TARGETplus SMARTpool siRNA (Dharmacon,
Thermo Fisher Scientific) via LipofectamineTM 2000 (Invitrogen). Before siRNA transfection,
cultures were plated at 1.5×105 RPE cells/well in 6-well plates with antibiotic-free complete
DMEM/F-12 medium for 24 hr. Upon 60%-70% cell confluence, 75 nM siHIF and/or 200 nM
siENO1 were transfected into cells by mixing with Lipofectamine in OptiMEM1I Reduced
SerumMedium (Invitrogen) according to the manufacturer’s protocol. The amount of siRNA
adopted had been optimized. After 24 hr of incubation, the medium was replaced with 1 ml
serum-free DMEMmedium and cells were challenged with CoCl2-induced hypoxia for another
24 hr. A non-targeting scramble siRNA with RISC-free modification (siGLO Green Transfec-
tion Detector, Dharmacon, Thermo Fisher Scientific) was included as the negative control. The
FAM-labeled siGLO with the green fluorescence displayed by successfully transfected cells can
also help to determine the transfection efficiency.
Lactate dehydrogenase (LDH) assay
Cytotoxic effects of various treatments to cells were assayed by LDH leakage into the medium,
which is an indicator of membrane breakage and cell death [27]. Cultured medium was col-
lected while cell lysates were obtained by addition of 2% Triton X-100 in 1 ml flesh serum-free
medium for overnight at 4°C. LDH activities in the supernatant of cell homogenate and the
medium were measured using the Cytotoxicity Detection Kit (LDH, Roche Applied Science,
Basel, Switzerland) according to the manufacturer’s instruction. Absorbance at 490 nm and
630 nm was measured by a microplate reader (Bio-Tek, Winooski, USA). Readings at 630 nm
were subtracted from the readings at 490 nm to allow correction for optical imperfections. Per-
cent leakage of LDH was calculated as {LDH activity in medium/ (LDH activity in medium
+ LDH activity in cells)} × 100%. Assays were repeated in triplicate.
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Protein collection andWestern blotting
After 24 hr of anoxic or hypoxic treatments, cells were rinsed with ice-cold PBS and immedi-
ately lysed with RIPA lysis buffer containing protease inhibitor and protein phosphatase inhib-
itor (Roche Applied Science) on ice. The whole cell lysate was harvested after centrifugation at
13200 rpm for 20 min at 4°C and the supernatant was quickly frozen with liquid nitrogen
before storage at -80°C. Protein concentration was determined by Bradford assay (Bio-Rad,
California, USA) using bovine serum albumin (BSA, Bio-Rad) as the standard.
The protein levels of HIF-1α and ENO1 were detected by Western blotting. SDS-PAGE was
performed at 90V in 4% stacking gel and 120V in 8% separating gel. Proteins were electro-
transferred onto a PVDF membrane (Millipore, Billerica, USA) via Mini Trans-blot Cell1
(Bio-Rad) at 120V for 1.5 hr on ice. After blocking with 5% skimmed milk in TBST for 1 hr,
the membranes were incubated overnight at 4°C with specific primary antibody for HIF-1α
(monoclonal, mouse, Thermo Scientific) or ENO1 (monoclonal, rabbit, Abcam, Cambridge,
UK). Due to the large difference in the molecular mass of HIF-1α and ENO1, β-actin (mouse,
Chemicon, Tokyo, Japan) or p84 (mouse, Genetex, Irvine, USA) was chosen, respectively as
internal loading controls. Immunoreactivities were visualized with HRP-conjugated secondary
antibodies (Vector Laboratories, Burlingame, USA) and ECL Chemiluminscent Substrate (GE
Healthcare, Little Chalfont, UK). The signals were captured using X-ray films (Fuji, Tokyo,
Japan) or a CCD camera-based imager (My ECL Imager, Thermo Fisher Scientific). Integrated
intensities of target bands on the Western blot images were determined by densitometric
image analysis using Image J software (National Institute of Health, Bethesda, USA). The band
intensity of the target protein was further normalized against β-actin or p84. Fold changes of
protein expressions were calculated versus the normal control level.
Enzyme-linked immunosorbent assay (ELISA) of VEGF
Culture medium was assayed for VEGF concentration using the Quantikine1Human VEGF
Immunoassay Kit (R&D Systems, Minneapolis, USA) according to the manufacturer’s instruc-
tions. Cell culture medium was collected and supplemented with 2% fetal bovine serum
(Hyclone) before storage at -20°C for maintaining the stability of VEGF. All reagents and stan-
dards were freshly prepared and added during the assay as instructed by the manufacturer. The
concentration of VEGF was measured by the color intensity of solutions using a microplate
reader (Bio-Tek) at 450 nm and 570 nm, respectively. Readings at 570 nm were subtracted
from the readings at 450 nm to allow correction for optical imperfections. VEGF concentra-
tions were obtained by comparing the corresponding readings with those of the standard curve
using known concentrations of VEGF. Assays were repeated in duplicate.
Statistical analysis
Statistical analyses were performed using the GraphPad Prism 6 software (GraphPad Software,
La Jolla, USA). Data presented as mean ± S.D. were analyzed by paired t-test (2 groups) or
one-way ANOVA (> 2 groups) followed by Bonferroni’ s post test [28]. The post tests were
performed only when the means of the groups were significantly different (p<0.05).
Results
No observable cell death in ARPE-19 cells after 24 hr of anoxia or
CoCl2-induced hypoxia
The overall cellular damage displayed by ARPE-19 cells in response to anoxia or hypoxia was
analyzed by LDH cytotoxicity assay. LDH is a cytoplasmic enzyme that is rapidly released into
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the surrounding medium upon cell damage. As a result, the activity of LDH in the medium is
proportional to the extent of cell death; the higher LDH activity indicates more cell damage
[27]. Interestingly, after 24 hr of anoxia or hypoxia, there appeared to be no observable cell
death in either anoxic-treated or CoCl2-treated ARPE-19 cells when compared with the nor-
moxic cells (Fig 1), a result similar to previous findings in cultured ARPE-19 cells upon 24 hr
of hypoxic treatment [22]. Morphological analysis by light microscopy also revealed no detect-
able cell death (data not shown).
Induction of HIF-1α and ENO1 in ARPE-19 cells upon 24 hr of anoxia or
hypoxia challenge
HIF-1α protein was barely detectable in ARPE-19 cells under normoxia (Fig 2A & 2B). After a
24-hr of either anoxia or CoCl2-induced hypoxia, HIF-1α levels were significantly elevated (Fig
2A & 2B). Moreover, the increase in HIF-1α protein level in ARPE-19 cells under CoCl2 chal-
lenge (~30 times) (Fig 2B) was much larger than under anoxia (~8 times) (Fig 2A). These
results indicated that HIF-1α was successfully induced by 24 hr of either treatment, with the
CoCl2-induced hypoxia causing a much stronger and more stable response from ARPE-19
cells than the anoxic treatment.
On the other hand, ENO1 protein was highly expressed in ARPE-19 cells under normal
condition (Fig 2C). Significant increases in ENO1 levels were also found in ARPE-19 cells
when exposed for 24 hr to either anoxia (Fig 2C) or CoCl2-induced hypoxia (Fig 2D). Hence,
we demonstrated that the expression of ENO1 is increased in ARPE-19 cells along with HIF-
1α after anoxia or CoCl2-induced hypoxia. Since the effect of CoCl2-induced hypoxia was
more stable and remarkable, only CoCl2 treatment was used in the rest of our experiments.
Transfection efficiency of siRNA in ARPE-19 cells
To further study the regulation and role of ENO1 in ARPE-19 cells in response to oxygen
depletion, siRNA was applied to mediate its down-regulation. Transfection efficiency of the
Fig 1. LDH analysis of ARPE-19 cell death after 24 hr of anoxia or CoCl2-induced hypoxia. Serum-
starved ARPE-19 cells were challenged with anoxia or CoCl2-induced hypoxia. LDH activities in the culture
medium were detected after 24 hr of treatment. No significant differences in the LDH activities were observed
in cells under normoxic, anoxic and CoCl2-induced hypoxic conditions. This implied that no remarkable cell
death (LDH release less than 5%) resulted from the anoxic or hypoxic stress in the cultured ARPE-19 cells.
(n = 4).
doi:10.1371/journal.pone.0147961.g001
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siRNA is an important factor for effective down-regulation of the target mRNA and protein.
The optimal siRNA transfection conditions in our study were determined using the FAM-
labeled RISC-independent control siRNA (siGLO) as the transfection indicator. After trans-
fecting the ARPE-19 cells with 75nM siGLO for 48 hr, more than 60% of the RPE cells dis-
played green fluorescence (Fig 3A & 3B). Meanwhile, the survival rates of transfected cells were
all over 85%. Single or co-transfection of siRNAs for HIF-1α and ENO1 had no effect on
ARPE-19 cell toxicity as assessed by LDH leakage assay (Fig 3C), similar to previous reports
[3]. Both conditions described above ensured that the majority of ARPE-19 cells were success-
fully transfected with siRNA and stayed alive in our experiments. There was also little/no dif-
ference in total protein content among various transfected cultures, as all siRNA transfection
did not cause cell damage or reduce protein synthesis.
Decreased ENO1 expression in HIF-1α-diminished ARPE-19 cell under
CoCl2-induced hypoxia
Knockdown of HIF-1α in the hypoxic ARPE-19 cells was performed using HIF-1α siRNA
(siHIF). The result of Western blotting showed a significant down-regulation of HIF-1α pro-
tein level in the siHIF-transfected ARPE-19 cells under hypoxic stress (Fig 4A). Meanwhile,
reduction of ENO1 expression was also observed when HIF-1α was successfully knocked
down. ENO1 protein level was decreased by about 30% in the HIF-1α-diminished ARPE-19
cell when compared with the negative control cells (Fig 4B).
siRNA-mediated knockdown and double-knockdown of ENO1 in ARPE-
19 cell under CoCl2-induced hypoxia
In order to further investigate the role of ENO1 in hypoxia, ENO1 siRNA (siENO) was used to
knock down ENO1 in the hypoxic ARPE-19 cells. As ENO1 is highly expressed in the retinal
pigment epithelial cells even under normoxia, the amount of siRNA was modified and
Fig 2. Changes in HIF-1α and ENO1 levels in ARPE-19 cells after 24 hr of anoxic or hypoxic treatment. ARPE-19 cells were cultured with
deoxygenated DMEMmedium or supplemented with 300μMCoCl2 for 24 hr. (A. B) Expression of HIF-1α (116kDa) and (C, D) ENO1 (46kDa) were assayed
byWestern blotting. β-actin (42kDa) and p84 (84kDa) were used, respectively as the internal control for equal loading of proteins. In ARPE-19 cells, HIF-1α
protein level was barely detectable under normoxia. (A) Upon 24 hr of anoxia, HIF-1α expression rose significantly (n = 3, *p < 0.05 versus normoxia). (B)
CoCl2-induced hypoxia also successfully increased HIF-1α protein levels in ARPE-19 cells (n = 6, ****p<0.001 versus normoxia). In contrast to the
normoxic control, the protein level of ENO1 increased significantly under both treatment conditions. (C) It approximately doubled after 24 hr of anoxia (n = 3,
**p<0.01 versus normoxia) while it was tripled in the CoCl2-treated cells. (n = 6, ***p<0.001 versus normoxia) (D).
doi:10.1371/journal.pone.0147961.g002
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optimized. The protein level of ENO1 in cells transfected with 200 nM siENO was decreased
by about 40% under hypoxia (Fig 5A), which was similar to the published results [3]. Co-trans-
fection with siHIF and siENOmanaged to further decrease ENO1 expressions in the hypoxic
ARPE-19 cells (Fig 5B). Conversely, knockdown of ENO1 had little/no effect on the induction
of HIF-1α in ARPE-19 cells under hypoxia (Fig 5C). This result is similar to the previously
reported results in cancer research [4] and suggested that ENO1 is the downstream product
and does not affect HIF-1α expression in ARPE-19 cells.
Changes in VEGF expression in ENO1-knockdown or HIF-1α &
ENO1-double knockdown ARPE-19 cells under hypoxia
ELISA results demonstrated that HIF-1α also controlled the up-regulation of VEGF in the hyp-
oxic RPE cells. Expression of VEGF was markedly augmented in ARPE-19 cells in response to
Fig 3. (A, B) Representative photomicrographs of ARPE-19 cells at 48 hr of transfection with FAM-labeled
siGLO RISC-free siRNA. RPE cells were transfected with scramble control siRNA (siGLO) for 24 hr and
subsequently cultured with 300μMCoCl2 for another 24 hr. Cell images were captured at 48 hr under bright
field (A) and fluorescence field with a FITC filter (B) at 200Xmagnification. Cells displayed green
fluorescence, indicating that they were transfected with FAM-labeled RISC-independent siRNA (siGLO),
which was used as both the scramble control and the transfection indicator. Under our experimental
condition, over 60% of cells showed observable fluorescence suggesting successful transfection after 48 hr.
(C) LDH analysis of transfected ARPE-19 cells under 24 hr of CoCl2-induced hypoxia. ARPE-19 cells were
transfected with scramble control siRNA (siGLO), HIF-1α siRNA (siHIF), ENO1 siRNA (siENO), and co-
transfected with both HIF-1α siRNA and ENO1 siRNA (siHIF + siENO) for 24 hr, followed by another 24 hr of
CoCl2-induced hypoxia before LDH assay. Compared with the control group, lack of changes in the LDH
activities were observed in the cells transfected with different targeting siRNA under CoCl2 challenge. All cell
survival rates were over 85%. (n = 4).
doi:10.1371/journal.pone.0147961.g003
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hypoxia (Fig 6 lanes 2&3), along with HIF-1α (Fig 2B) and ENO1 (Fig 2D). Decreasing HIF-1α
expression by siRNA in the hypoxic ARPE-19 cells managed to down-regulate the VEGF secre-
tion (Fig 6 lane 4) as well as ENO1 expression (Fig 4B). However, VEGF was only partially sup-
pressed in the HIF-1α-diminished ARPE-19 cells under hypoxia challenge and its level was
still a little higher than that in normal condition (Fig 6 lanes 1&4). Interestingly, knockdown of
ENO1 turned out not to help alleviate VEGF secretion upon hypoxia. The level of VEGF in
siENO-transfected ARPE 19 cells remained nearly the same as that in the normal and siGLO-
transfected cells under hypoxia (Fig 6 lane 5). Moreover, double-knockdown of HIF-1α and
ENO1 could not further down-regulate VEGF secretion, which was very similar to that in the
HIF-1α-diminished cells (Fig 6 lanes 4&6).
Discussion
HIF-1α is the master transcriptional factor of various angiogenic factors (e.g. VEGF) involved
in CNV [29]. It is hardly stable and detectable under normoxia. However, external stress such
as depletion of oxygen would inhibit the degradation of HIF-1α [30, 31]. Although either
anoxia or CoCl2–induced hypoxia could significantly increase HIF-1α expression in ARPE-19
cells, the respective levels of HIF-1α up-regulation seemed different. According to our results,
HIF-1α protein induction appeared to be more prominent upon 24 hr of CoCl2–induced hyp-
oxia in contrast to anoxia. In fact, CoCl2-induced hypoxia appeared to be more pronounced
and stable, reducing the degradation of HIF-1α in a dose-dependent response. Therefore,
CoCl2-induced hypoxia was chosen as the treatment in later experiments.
Fig 4. Changes of HIF-1α & ENO1 levels in siHIF-transfected ARPE-19 cells at 24 hr of hypoxia. ARPE
cells were transfected with scramble control (siGLO) or HIF-1α siRNA (siHIF) for 24 hr, and cultured with
300μMCoCl2 for another 24 hr. Expressions of HIF-1α and ENO1 were assayed byWestern blotting. β-actin
and p84 were used as the internal controls, respectively. (A) Upon transfection with siHIF, the HIF-1α level
under hypoxia condition was clearly reduced when compared with the control cells transfected with siGLO
(n = 6, ****p< 0.0001). (B) The expression of ENO1 in the hypoxic ARPE-19 cells displayed a decrease by
about 30% upon HIF-1α diminished (n = 6, ****p< 0.0001).
doi:10.1371/journal.pone.0147961.g004
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ENO1 has been identified as a hypoxic stress protein in vascular endothelial cells, where its
protein level rose to nearly three fold at 24 hr of anoxic exposure [32], similar to our results
obtained from retinal pigment epithelial cells. In previous proteomic studies, ENO1 was found
in ARPE-19 cells [33] and changes in ENO1 expression were observed during chick retinogen-
esis [34]. Herein, we are the first to demonstrate that ENO1 is one of the distinct proteins that
is up-regulated in the retinal pigment epithelial cells by hypoxia, in conformity with the find-
ings in cancer angiogenesis.
Analysis of ENO1 gene has revealed that ENO1 promoter contains a hypoxia responsive ele-
ment (HRE). In response to hypoxia, accumulated HIF-1α activates the transcription of ENO1
by recognizing HRE, as is the case for VEGF activation [2, 9, 35–37]. The mRNA and protein
levels of ENO1 and VEGF can therefore be induced by HIF-1α in hypoxic retinal pigment epi-
thelial cells.
Fig 5. Changes of ENO1 and HIF-1α levels in siENO-transfected ARPE-19 cells at 24 hr of hypoxia. (A)
ARPE-19 cells were transfected with siENO for 48 hr. In the meantime, cells were exposed to CoCl2-induced
hypoxia for the last 24 hr. The protein level of ENO1managed to be reduced by about 40% in the hypoxic
ARPE-19 cells. (B) ARPE cells were (co-)transfected with scramble control siRNA (siGLO), HIF-1α siRNA
(siHIF) and/or ENO1 siRNA (siENO) for 24 hr, respectively and cultured with 300μMCoCl2 for another 24 hr.
ENO1 protein was successfully suppressed by transfecting with siENO (~40%), the expression of which was
further knocked down by co-transfecting with both siHIF and siENO (~60%) (n = 4, ****p<0.0001 versus
siGLO respectively; # p<0.0001). (C) Under hypoxia, HIF-1α protein was significantly decreased (~60%) in
ARPE-19 cells with the transfection of siHIF. Co-transfection with siHIF and siENO did not further down-
regulate the protein level of HIF-1α, which was nearly the same as that in the siHIF-transfected cells (n = 4,
****p<0.0001 versus siGLO respectively). (c, d).
doi:10.1371/journal.pone.0147961.g005
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VEGF is a potent pro-angiogenic factor produced by retinal pigment epithelial cells and a
well-known HIF-1-dependent factor. We showed that ENO1 level did not change VEGF
expression in retinal pigment epithelial cells, indicating that either ENO1 or VEGF is indepen-
dently induced by hypoxia and ENO1 may not play a role in regulating VEGF secretion in reti-
nal pigment epithelial cells. Since overexpression of ENO1 has been demonstrated to promote
proliferation and migration of endothelial cells, it is likely that pathways other than VEGF may
be involved.
The potential role and mechanism of ENO1 in promoting retinal angiogenesis has yet to be
understood. Some ENO1-regulated proteins have been identified using two-dimensional elec-
trophoresis, including C1 esterase, pyruvate kinase, and FR-β in our preliminary work [38].
Further studies in examining how knockdown of ENO1 affects the migration and proliferation
of endothelial cells will help to decipher the involvement of ENO1 in retinal angiogenesis. The
effect of ENO1 alteration on VEGF receptor expression on endothelial cells may also help to
clarify this point.
Conclusion
ENO1 exists in the retinal pigment epithelium at high concentration. When the retinal pigment
epithelial cells and the choroid are subjected to pathological hypoxia or ischemia, expression of
Fig 6. VEGF secretion in ARPE-19 cells at 24 hr of normoxia or hypoxic treatment. Culture medium was
assayed for VEGF secretion by ELISA. (Lanes 1&2) VEGF secretion in ARPE-19 cells was strongly induced
in response to hypoxia. (Lanes 3&4) Down-regulation of HIF-1αmarkedly but not completely alleviated VEGF
level in ARPE-19 cells. The level of VEGF secretion in HIF-1α-diminished ARPE 19 cells was still higher than
that under normoxia. (Lanes 3&5) VEGF secretion in ENO1-knockdown ARPE 19 cells remained nearly the
same as siGLO-transfected cells under hypoxia. (Lanes 3, 4&5) Double-knockdown of HIF-1α and ENO1
significantly down-regulated VEGF level when compared with that in the singly ENO1-diminished cells, while
it appeared unchanged when compared with that in the HIF-1α knockdown cells. (n = 4, **p<0.01,
***p<0.001, ****p<0.0001, versus normoxia respectively; #p<0.0001).
doi:10.1371/journal.pone.0147961.g006
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ENO1 is up-regulated in the retinal pigment epithelial cells mediated by HIF-1α, which also
increases VEGF secretion in the retinal pigment epithelium. Nevertheless, ENO1 has no effect
on influencing VEGF expression in the retinal pigment epithelial cells, which means that they
are independently regulated by HIF-1α without mutual interference. Together with VEGF up-
regulation, over-expression of ENO1 in the retinal pigment epithelium in response to hypoxia
may suggest a potential positive role in the development of CNV.
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